Barriers to the Use of Medicinal Mushrooms for Production of Metabolites : The Bjarmin Rushton Story

Adv Biochem Eng Biotechnol. 2023:184:107-123. doi: 10.1007/10_2021_188.

Abstract

Traditionalists are reluctant to leave the technology they and their forefathers knew. To them the new technology based on the stirred tank bioreactor is too removed from the soil the mushroom comes from. On the other hand, there are examples of applications of a bioreactor which support the change from the old to the new technology. In this chapter Bjarmin Rushton, the creator of the well-known medicinal mushroom company Wellness, gives his view of the much talked about difficulties with cultivation in stirred tanks. These problems, are they real or figment of our imagination? Those who read will find out.

Keywords: Liquid cultivation; Medicinal mushrooms biomass; Scale-up; Stirred tank reactor.

MeSH terms

  • Agaricales*
  • Bioreactors